Therefore, given the close proximity of tumor cells, their surrounding stroma, and infiltrating lymphocytes, we analyzed the immunohistochemical expression and histological localization of Bcl-2 in ovarian the stromal and epithelial components of normal, benign, and cancer clinical specimens as well as evaluated changes in lymphocyte populations with ovarian tumor progression. The gene discussed is BCL2; the disease is ovarian neoplasm.